-
1
-
-
29144453326
-
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
-
Nathan DM, Cleary PA, Backlund JY, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353(25):2643-2653.
-
(2005)
N Engl J Med
, vol.353
, Issue.25
, pp. 2643-2653
-
-
Nathan, D.M.1
Cleary, P.A.2
Backlund, J.Y.3
-
2
-
-
84901212150
-
Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus
-
Fullerton B, Jeitler K, Seitz M, Horvath K, Berghold A, Siebenhofer A. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus. Cochrane Database Syst Rev. 2014;2:CD009122.
-
(2014)
Cochrane Database Syst Rev
, vol.2
-
-
Fullerton, B.1
Jeitler, K.2
Seitz, M.3
Horvath, K.4
Berghold, A.5
Siebenhofer, A.6
-
3
-
-
85019942593
-
Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials
-
Weisman A, Bai JW, Cardinez M, Kramer CK, Perkins BA. Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials. The lancet Diabetes & endocrinology. 2017;5(7):501-512.
-
(2017)
The lancet Diabetes & endocrinology
, vol.5
, Issue.7
, pp. 501-512
-
-
Weisman, A.1
Bai, J.W.2
Cardinez, M.3
Kramer, C.K.4
Perkins, B.A.5
-
4
-
-
84948716018
-
Glycaemic control of type 1 diabetes in clinical practice early in the 21st century: an international comparison
-
McKnight JA, Wild SH, Lamb MJ, et al. Glycaemic control of type 1 diabetes in clinical practice early in the 21st century: an international comparison. Diabet Med. 2015;32(8):1036-1050.
-
(2015)
Diabet Med
, vol.32
, Issue.8
, pp. 1036-1050
-
-
McKnight, J.A.1
Wild, S.H.2
Lamb, M.J.3
-
5
-
-
84879274635
-
Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines
-
Wood JR, Miller KM, Maahs DM, et al. Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines. Diabetes Care. 2013;36(7):2035-2037.
-
(2013)
Diabetes Care
, vol.36
, Issue.7
, pp. 2035-2037
-
-
Wood, J.R.1
Miller, K.M.2
Maahs, D.M.3
-
6
-
-
84871995815
-
Standards of medical care in diabetes—2013
-
Standards of medical care in diabetes—2013. Diabetes Care. 2013;36(Suppl 1):S11-S66.
-
(2013)
Diabetes Care
, vol.36
, pp. S11-S66
-
-
-
7
-
-
85020425866
-
Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial
-
Petrie JR, Chaturvedi N, Ford I, et al. Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial. The lancet Diabetes & endocrinology. 2017;5(8):597-609.
-
(2017)
The lancet Diabetes & endocrinology.
, vol.5
, Issue.8
, pp. 597-609
-
-
Petrie, J.R.1
Chaturvedi, N.2
Ford, I.3
-
8
-
-
33748750517
-
The effect of metformin on blood glucose control in overweight patients with type 1 diabetes
-
Khan AS, McLoughney CR, Ahmed AB. The effect of metformin on blood glucose control in overweight patients with type 1 diabetes. Diabet Med. 2006;23(10):1079-1084.
-
(2006)
Diabet Med
, vol.23
, Issue.10
, pp. 1079-1084
-
-
Khan, A.S.1
McLoughney, C.R.2
Ahmed, A.B.3
-
9
-
-
68949198356
-
The effect of metformin in overweight patients with type 1 diabetes and poor metabolic control
-
Jacobsen IB, Henriksen JE, Beck-Nielsen H. The effect of metformin in overweight patients with type 1 diabetes and poor metabolic control. Basic Clin Pharmacol Toxicol. 2009;105(3):145-149.
-
(2009)
Basic Clin Pharmacol Toxicol
, vol.105
, Issue.3
, pp. 145-149
-
-
Jacobsen, I.B.1
Henriksen, J.E.2
Beck-Nielsen, H.3
-
10
-
-
0142154262
-
Metformin as additional therapy in adolescents with poorly controlled type 1 diabetes: randomised placebo-controlled trial with aspects on insulin sensitivity
-
Sarnblad S, Kroon M, Aman J. Metformin as additional therapy in adolescents with poorly controlled type 1 diabetes: randomised placebo-controlled trial with aspects on insulin sensitivity. Eur J Endocrinol. 2003;149(4):323-329.
-
(2003)
Eur J Endocrinol
, vol.149
, Issue.4
, pp. 323-329
-
-
Sarnblad, S.1
Kroon, M.2
Aman, J.3
-
11
-
-
0038782791
-
The benefits of metformin therapy during continuous subcutaneous insulin infusion treatment of type 1 diabetic patients
-
Meyer L, Bohme P, Delbachian I, et al. The benefits of metformin therapy during continuous subcutaneous insulin infusion treatment of type 1 diabetic patients. Diabetes Care. 2002;25(12):2153-2158.
-
(2002)
Diabetes Care
, vol.25
, Issue.12
, pp. 2153-2158
-
-
Meyer, L.1
Bohme, P.2
Delbachian, I.3
-
12
-
-
84926171076
-
Effects of low dose metformin in adolescents with type I diabetes mellitus: a randomized, double-blinded placebo-controlled study
-
Nadeau KJ, Chow K, Alam S, et al. Effects of low dose metformin in adolescents with type I diabetes mellitus: a randomized, double-blinded placebo-controlled study. Pediatr Diabetes. 2015;16(3):196-203.
-
(2015)
Pediatr Diabetes
, vol.16
, Issue.3
, pp. 196-203
-
-
Nadeau, K.J.1
Chow, K.2
Alam, S.3
-
13
-
-
84922450117
-
Efficacy and safety of metformin for patients with type 1 diabetes mellitus: a meta-analysis
-
Liu C, Wu D, Zheng X, Li P, Li L. Efficacy and safety of metformin for patients with type 1 diabetes mellitus: a meta-analysis. Diabetes Technol Ther. 2015;17(2):142-148.
-
(2015)
Diabetes Technol Ther
, vol.17
, Issue.2
, pp. 142-148
-
-
Liu, C.1
Wu, D.2
Zheng, X.3
Li, P.4
Li, L.5
-
14
-
-
77952094084
-
The use of metformin in type 1 diabetes: a systematic review of efficacy
-
Vella S, Buetow L, Royle P, Livingstone S, Colhoun HM, Petrie JR. The use of metformin in type 1 diabetes: a systematic review of efficacy. Diabetologia. 2010;53(5):809-820.
-
(2010)
Diabetologia
, vol.53
, Issue.5
, pp. 809-820
-
-
Vella, S.1
Buetow, L.2
Royle, P.3
Livingstone, S.4
Colhoun, H.M.5
Petrie, J.R.6
-
15
-
-
84890079851
-
Metformin for the treatment of hyperandrogenism in adolescents with type 1 diabetes mellitus
-
Codner E, Iniguez G, Lopez P, et al. Metformin for the treatment of hyperandrogenism in adolescents with type 1 diabetes mellitus. Horm Res Paediatr. 2013;80(5):343-349.
-
(2013)
Horm Res Paediatr
, vol.80
, Issue.5
, pp. 343-349
-
-
Codner, E.1
Iniguez, G.2
Lopez, P.3
-
16
-
-
84947745206
-
A randomized, double-blind, placebo-controlled trial of adjunctive metformin therapy in overweight/obese youth with type 1 diabetes
-
Nwosu BU, Maranda L, Cullen K, et al. A randomized, double-blind, placebo-controlled trial of adjunctive metformin therapy in overweight/obese youth with type 1 diabetes. PLoS One. 2015;10(9):e0137525.
-
(2015)
PLoS One
, vol.10
, Issue.9
-
-
Nwosu, B.U.1
Maranda, L.2
Cullen, K.3
-
17
-
-
84949522230
-
Effect of metformin added to insulin on glycemic control among overweight/obese adolescents with type 1 diabetes: a randomized clinical trial
-
Libman IM, Miller KM, DiMeglio LA, et al. Effect of metformin added to insulin on glycemic control among overweight/obese adolescents with type 1 diabetes: a randomized clinical trial. JAMA. 2015;314(21):2241-2250.
-
(2015)
JAMA
, vol.314
, Issue.21
, pp. 2241-2250
-
-
Libman, I.M.1
Miller, K.M.2
DiMeglio, L.A.3
-
18
-
-
84859001212
-
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
-
Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343(oct18 2):d5928.
-
(2011)
BMJ
, vol.343
, Issue.oct18 2
-
-
Higgins, J.P.1
Altman, D.G.2
Gotzsche, P.C.3
-
19
-
-
84876340948
-
Metformin improves endothelial function in type 1 diabetic subjects: a pilot, placebo-controlled randomized study
-
Pitocco D, Zaccardi F, Tarzia P, et al. Metformin improves endothelial function in type 1 diabetic subjects: a pilot, placebo-controlled randomized study. Diabetes Obes Metab. 2013;15(5):427-431.
-
(2013)
Diabetes Obes Metab
, vol.15
, Issue.5
, pp. 427-431
-
-
Pitocco, D.1
Zaccardi, F.2
Tarzia, P.3
-
20
-
-
0037768213
-
Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial
-
Hamilton J, Cummings E, Zdravkovic V, Finegood D, Daneman D. Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial. Diabetes Care. 2003;26(1):138-143.
-
(2003)
Diabetes Care
, vol.26
, Issue.1
, pp. 138-143
-
-
Hamilton, J.1
Cummings, E.2
Zdravkovic, V.3
Finegood, D.4
Daneman, D.5
-
21
-
-
54449097429
-
Effect of adjunct metformin treatment in patients with type-1 diabetes and persistent inadequate glycaemic control. A randomized study
-
Lund SS, Tarnow L, Astrup AS, et al. Effect of adjunct metformin treatment in patients with type-1 diabetes and persistent inadequate glycaemic control. A randomized study. PLoS One. 2008;3(10):e3363.
-
(2008)
PLoS One
, vol.3
, Issue.10
-
-
Lund, S.S.1
Tarnow, L.2
Astrup, A.S.3
-
22
-
-
70349762895
-
Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetes
-
Lund SS, Tarnow L, Astrup AS, et al. Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetes. Diabetes Obes Metab. 2009;11(10):966-977.
-
(2009)
Diabetes Obes Metab
, vol.11
, Issue.10
, pp. 966-977
-
-
Lund, S.S.1
Tarnow, L.2
Astrup, A.S.3
-
23
-
-
85011675601
-
The effect of adding metformin to insulin therapy for type 1 diabetes mellitus children: a systematic review and meta-analysis
-
Al Khalifah RA, Alnhdi A, Alghar H, Alanazi M, Florez ID. The effect of adding metformin to insulin therapy for type 1 diabetes mellitus children: a systematic review and meta-analysis. Pediatr Diabetes. 2017;18(7):664-673.
-
(2017)
Pediatr Diabetes
, vol.18
, Issue.7
, pp. 664-673
-
-
Al Khalifah, R.A.1
Alnhdi, A.2
Alghar, H.3
Alanazi, M.4
Florez, I.D.5
-
24
-
-
0031614038
-
Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes
-
Lee A, Morley JE. Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes. Obes Res. 1998;6(1):47-53.
-
(1998)
Obes Res
, vol.6
, Issue.1
, pp. 47-53
-
-
Lee, A.1
Morley, J.E.2
-
26
-
-
70449526185
-
Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: a post-hoc analysis of the BIGPRO1 trial
-
Fontbonne A, Diouf I, Baccara-Dinet M, Eschwege E, Charles MA. Effects of 1-year treatment with metformin on metabolic and cardiovascular risk factors in non-diabetic upper-body obese subjects with mild glucose anomalies: a post-hoc analysis of the BIGPRO1 trial. Diabetes Metab. 2009;35(5):385-391.
-
(2009)
Diabetes Metab
, vol.35
, Issue.5
, pp. 385-391
-
-
Fontbonne, A.1
Diouf, I.2
Baccara-Dinet, M.3
Eschwege, E.4
Charles, M.A.5
-
27
-
-
84876293806
-
Metformin modifies the exercise training effects on risk factors for cardiovascular disease in impaired glucose tolerant adults
-
Malin SK, Nightingale J, Choi SE, Chipkin SR, Braun B. Metformin modifies the exercise training effects on risk factors for cardiovascular disease in impaired glucose tolerant adults. Obesity (Silver Spring). 2013;21(1):93-100.
-
(2013)
Obesity (Silver Spring)
, vol.21
, Issue.1
, pp. 93-100
-
-
Malin, S.K.1
Nightingale, J.2
Choi, S.E.3
Chipkin, S.R.4
Braun, B.5
-
28
-
-
84924736924
-
Effects of metformin on energy intake and satiety in obese children
-
Adeyemo MA, McDuffie JR, Kozlosky M, et al. Effects of metformin on energy intake and satiety in obese children. Diabetes Obes Metab. 2015;17(4):363-370.
-
(2015)
Diabetes Obes Metab
, vol.17
, Issue.4
, pp. 363-370
-
-
Adeyemo, M.A.1
McDuffie, J.R.2
Kozlosky, M.3
-
29
-
-
0034914193
-
Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30
-
Glueck CJ, Fontaine RN, Wang P, et al. Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30. Metabolism. 2001;50(7):856-861.
-
(2001)
Metabolism
, vol.50
, Issue.7
, pp. 856-861
-
-
Glueck, C.J.1
Fontaine, R.N.2
Wang, P.3
-
30
-
-
84962374537
-
Effects of metformin on metabolite profiles and LDL cholesterol in patients with type 2 diabetes
-
Xu T, Brandmaier S, Messias AC, et al. Effects of metformin on metabolite profiles and LDL cholesterol in patients with type 2 diabetes. Diabetes Care. 2015;38(10):1858-1867.
-
(2015)
Diabetes Care
, vol.38
, Issue.10
, pp. 1858-1867
-
-
Xu, T.1
Brandmaier, S.2
Messias, A.C.3
-
32
-
-
0142057121
-
Obesity and health-related quality of life: a cross-sectional analysis of the US population
-
Hassan MK, Joshi AV, Madhavan SS, Amonkar MM. Obesity and health-related quality of life: a cross-sectional analysis of the US population. Int J Obes Relat Metab Disord. 2003;27(10):1227-1232.
-
(2003)
Int J Obes Relat Metab Disord
, vol.27
, Issue.10
, pp. 1227-1232
-
-
Hassan, M.K.1
Joshi, A.V.2
Madhavan, S.S.3
Amonkar, M.M.4
-
33
-
-
0032496876
-
Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial
-
Purnell JQ, Hokanson JE, Marcovina SM, Steffes MW, Cleary PA, Brunzell JD. Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes Control and Complications Trial. JAMA. 1998;280(2):140-146.
-
(1998)
JAMA
, vol.280
, Issue.2
, pp. 140-146
-
-
Purnell, J.Q.1
Hokanson, J.E.2
Marcovina, S.M.3
Steffes, M.W.4
Cleary, P.A.5
Brunzell, J.D.6
-
34
-
-
84868116559
-
Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study
-
Livingstone SJ, Looker HC, Hothersall EJ, et al. Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study. PLoS Med. 2012;9(10):e1001321.
-
(2012)
PLoS Med
, vol.9
, Issue.10
-
-
Livingstone, S.J.1
Looker, H.C.2
Hothersall, E.J.3
-
35
-
-
84920509071
-
Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010
-
Livingstone SJ, Levin D, Looker HC, et al. Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010. JAMA. 2015;313(1):37-44.
-
(2015)
JAMA
, vol.313
, Issue.1
, pp. 37-44
-
-
Livingstone, S.J.1
Levin, D.2
Looker, H.C.3
|